| Product NDC: | 63323-307 |
| Proprietary Name: | Tobramycin |
| Non Proprietary Name: | TOBRAMYCIN SULFATE |
| Active Ingredient(s): | 40 mg/mL & nbsp; TOBRAMYCIN SULFATE |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 63323-307 |
| Labeler Name: | Fresenius Kabi USA, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065120 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20041130 |
| Package NDC: | 63323-307-51 |
| Package Description: | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-307-51) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| NDC Code | 63323-307-51 |
| Proprietary Name | Tobramycin |
| Package Description | 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (63323-307-51) > 50 mL in 1 VIAL, PHARMACY BULK PACKAGE |
| Product NDC | 63323-307 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | TOBRAMYCIN SULFATE |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20041130 |
| Marketing Category Name | ANDA |
| Labeler Name | Fresenius Kabi USA, LLC |
| Substance Name | TOBRAMYCIN SULFATE |
| Strength Number | 40 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient] |